Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

2.27p
   
  • Change Today:
      0.045p
  • 52 Week High: 3.93p
  • 52 Week Low: 1.10p
  • Currency: UK Pounds
  • Shares Issued: 979.75m
  • Volume: 22,354,163
  • Market Cap: 22.24m
  • RiskGrade: 340

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-22 Interim n/a (1.14) (0.20)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (2.41) (0.91)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (1.59) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (1.49) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (2.10) (0.50)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.11) (0.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

HEMO Market Data

Currency UK Pounds
Share Price 2.27p
Change Today 0.045p
% Change 2.02 %
52 Week High 3.93p
52 Week Low 1.10p
Volume 22,354,163
Shares Issued 979.75m
Market Cap 22.24m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.13% below the market average19.13% below the market average19.13% below the market average19.13% below the market average19.13% below the market average
20.69% below the sector average20.69% below the sector average20.69% below the sector average20.69% below the sector average20.69% below the sector average
Price Trend
47.80% above the market average47.80% above the market average47.80% above the market average47.80% above the market average47.80% above the market average
58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 01-Feb-2023

Time Volume / Share Price
17:12 500,000 @ 2.27p
17:12 750,769 @ 2.27p
15:05 700,000 @ 2.30p
16:36 500,000 @ 2.27p
16:35 400,000 @ 2.27p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page